Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1997 1
2000 1
2007 1
2010 1
2012 1
2014 1
2016 4
2017 3
2018 1
2020 2
2021 4
2022 2
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M; the New Technology for Cervical Cancer 2 Working Group. Giorgi Rossi P, et al. Among authors: bulletti s. J Natl Cancer Inst. 2021 Mar 1;113(3):292-300. doi: 10.1093/jnci/djaa105. J Natl Cancer Inst. 2021. PMID: 32745170 Free PMC article.
Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
Benevolo M, Ronco G, Mancuso P, Carozzi F, De Marco L, Allia E, Bisanzi S, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Viti J, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Bonvicini L, Venturelli F, Wentzensen N, Giorgi Rossi P; NTCC2 Working Group. Benevolo M, et al. Among authors: bulletti s. EBioMedicine. 2024 Jun;104:105149. doi: 10.1016/j.ebiom.2024.105149. Epub 2024 May 17. EBioMedicine. 2024. PMID: 38759278 Free PMC article.
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.
Giorgi Rossi P, Ronco G, Mancuso P, Carozzi F, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Venturelli F, Benevolo M; NTCC2 Working Group. Giorgi Rossi P, et al. Among authors: bulletti s. Int J Cancer. 2022 Oct 1;151(7):1047-1058. doi: 10.1002/ijc.34120. Epub 2022 Jun 7. Int J Cancer. 2022. PMID: 35579975 Clinical Trial.
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
Gustinucci D, Benevolo M, Cesarini E, Mancuso P, Passamonti B, Giaimo MD, Corvetti R, Nofrini V, Bulletti S, Malaspina M, Tintori B, Giorgi Rossi P; Umbria HPV Screening Working Group. Gustinucci D, et al. Among authors: bulletti s. Int J Cancer. 2022 Mar 15;150(6):952-960. doi: 10.1002/ijc.33858. Epub 2021 Nov 5. Int J Cancer. 2022. PMID: 34706093
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Benevolo M, et al. Among authors: bulletti s. Cancer Cytopathol. 2021 May;129(5):383-393. doi: 10.1002/cncy.22385. Epub 2020 Nov 3. Cancer Cytopathol. 2021. PMID: 33142029 Free article.
Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Carlinfante G, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 Working Group. Benevolo M, et al. Among authors: bulletti s. Cancer Cytopathol. 2020 May;128(5):323-332. doi: 10.1002/cncy.22248. Epub 2020 Feb 12. Cancer Cytopathol. 2020. PMID: 32168431 Free article.
Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.
Benevolo M, Allia E, Gustinucci D, Rollo F, Bulletti S, Cesarini E, Passamonti B, Giovagnoli MR, Carico E, Carozzi FM, Mongia A, Fantacci G, Confortini M, Rubino T, Fodero C, Prandi S, Marchi N, Farruggio A, Coccia A, Macrì L, Ghiringhello B, Ronco G, Bragantini E, Polla E, Maccallini V, Negri G, Giorgi Rossi P; New Technologies for Cervical Cancer Screening 2 (NTCC2) Working Group. Benevolo M, et al. Among authors: bulletti s. Cancer Cytopathol. 2017 Mar;125(3):212-220. doi: 10.1002/cncy.21800. Epub 2016 Dec 7. Cancer Cytopathol. 2017. PMID: 27926800 Free article.
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
Gori S, Battagello J, Gustinucci D, Campari C, Zorzi M, Frayle H, Passamonti B, Sartori G, Bulletti S, Fodero C, Cesarini E, Faggiano R, Del Mistro A. Gori S, et al. Among authors: bulletti s. BJOG. 2021 Jul;128(8):1353-1362. doi: 10.1111/1471-0528.16631. Epub 2021 Jan 12. BJOG. 2021. PMID: 33326680 Free PMC article.
Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
Gustinucci D, Giorgi Rossi P, Cesarini E, Broccolini M, Bulletti S, Carlani A, D'angelo V, D'amico MR, Di Dato E, Galeazzi P, Malaspina M, Martinelli N, Spita N, Tintori B, Giaimo MD, Passamonti B. Gustinucci D, et al. Among authors: bulletti s. Am J Clin Pathol. 2016 Jan;145(1):35-45. doi: 10.1093/ajcp/aqv019. Am J Clin Pathol. 2016. PMID: 26712869
A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
Passamonti B, Malaspina M, Fraser CG, Tintori B, Carlani A, D'Angelo V, Galeazzi P, Di Dato E, Mariotti L, Bulletti S, D'Amico MR, Gustinucci D, Martinelli N, Spita N, Cesarini E, Rubeca T, Giaimo M, Segnan N, Senore C. Passamonti B, et al. Among authors: bulletti s. Gut. 2018 Mar;67(3):485-496. doi: 10.1136/gutjnl-2016-312716. Epub 2016 Dec 14. Gut. 2018. PMID: 27974550 Clinical Trial.
21 results